TCR-pMHC recognition mediates target phagocytosis by T cells

IF 3.1
Mechanobiology in Medicine Pub Date : 2026-03-01 Epub Date: 2026-02-24 DOI:10.1016/j.mbm.2026.100177
Xiangcheng Chen , Maximilian Wang , Ning Jiang
{"title":"TCR-pMHC recognition mediates target phagocytosis by T cells","authors":"Xiangcheng Chen ,&nbsp;Maximilian Wang ,&nbsp;Ning Jiang","doi":"10.1016/j.mbm.2026.100177","DOIUrl":null,"url":null,"abstract":"<div><div>T cells are traditionally viewed as non-phagocytic lymphocytes that recognize antigens via the T cell receptor (TCR) and mediate cytotoxicity at the immunological synapse, while phagocytosis is performed by professional phagocytes such as macrophages and dendritic cells. Here we show that peptide–MHC (pMHC) recognition alone is sufficient to drive rapid, antigen-specific phagocytosis by Jurkat T cells. We generated CD8<sup>+</sup> Jurkat cells expressing a class I–restricted human TCR (SVAR16) with intermediate-to-high 2-dimensional (2D) affinity for the SARS-CoV-2 epitope HLA∗A2:01–YLQ and used a micropipette system to control and image T cell interaction with pMHC coated beads. Upon contact with cognate YLQ-coated beads, SVAR16 transduced CD8<sup>+</sup> Jurkat cells consistently formed phagosomes within minutes and completely internalized beads with consistent kinetics. These results demonstrate that appropriately tuned TCR–pMHC interactions, supported by CD8 co-receptors, can convert a canonical CD4<sup>+</sup> T cell line into an antigen-specific phagocyte. This work reports a novel effector function of T cells and suggests that TCR-engineering could convert CD4<sup>+</sup> T cells into phagocytes, potentially revealing a new approach to T cell-based cancer immunotherapy.</div></div>","PeriodicalId":100900,"journal":{"name":"Mechanobiology in Medicine","volume":"4 1","pages":"Article 100177"},"PeriodicalIF":3.1000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mechanobiology in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949907026000045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

T cells are traditionally viewed as non-phagocytic lymphocytes that recognize antigens via the T cell receptor (TCR) and mediate cytotoxicity at the immunological synapse, while phagocytosis is performed by professional phagocytes such as macrophages and dendritic cells. Here we show that peptide–MHC (pMHC) recognition alone is sufficient to drive rapid, antigen-specific phagocytosis by Jurkat T cells. We generated CD8+ Jurkat cells expressing a class I–restricted human TCR (SVAR16) with intermediate-to-high 2-dimensional (2D) affinity for the SARS-CoV-2 epitope HLA∗A2:01–YLQ and used a micropipette system to control and image T cell interaction with pMHC coated beads. Upon contact with cognate YLQ-coated beads, SVAR16 transduced CD8+ Jurkat cells consistently formed phagosomes within minutes and completely internalized beads with consistent kinetics. These results demonstrate that appropriately tuned TCR–pMHC interactions, supported by CD8 co-receptors, can convert a canonical CD4+ T cell line into an antigen-specific phagocyte. This work reports a novel effector function of T cells and suggests that TCR-engineering could convert CD4+ T cells into phagocytes, potentially revealing a new approach to T cell-based cancer immunotherapy.

Abstract Image

TCR-pMHC识别介导T细胞靶向吞噬
传统上,T细胞被视为非吞噬性淋巴细胞,通过T细胞受体(TCR)识别抗原,并在免疫突触介导细胞毒性,而吞噬作用则由巨噬细胞和树突状细胞等专业吞噬细胞完成。在这里,我们表明肽- mhc (pMHC)识别本身就足以驱动Jurkat T细胞快速,抗原特异性吞噬。我们生成了表达一类限制性人TCR (SVAR16)的CD8+ Jurkat细胞,该细胞对SARS-CoV-2表位HLA∗A2:01-YLQ具有中至高的二维(2D)亲和力,并使用微管系统来控制和成像T细胞与pMHC包被珠的相互作用。与同源ylq包被珠粒接触后,SVAR16转导的CD8+ Jurkat细胞在几分钟内一致地形成吞噬体,并以一致的动力学完全内化珠粒。这些结果表明,在CD8共受体的支持下,适当调节TCR-pMHC相互作用可以将典型CD4+ T细胞系转化为抗原特异性吞噬细胞。这项工作报道了T细胞的一种新的效应功能,并表明tcr工程可以将CD4+ T细胞转化为吞噬细胞,潜在地揭示了一种基于T细胞的癌症免疫治疗的新方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书